大博医疗股价微跌0.37% 上半年净利润增长76.69%

Company Overview - Dabo Medical focuses on the research, production, and sales of high-value consumables for orthopedic implants, covering trauma, spine, and joint fields [1]. Financial Performance - For the first half of 2025, Dabo Medical reported a revenue of 1.21 billion yuan, representing a year-on-year growth of 25.55% [1]. - The net profit attributable to shareholders reached 244 million yuan, showing a significant increase of 76.69% year-on-year [1]. - Revenue from trauma products was 468 million yuan, up 23.68% year-on-year, while spine product revenue was 217 million yuan, reflecting a growth of 29.86% [1]. Market Activity - As of August 21, 2025, Dabo Medical's stock price closed at 58.50 yuan, down 0.37% from the previous trading day [1]. - The trading volume for the day was 270 million yuan, with a price fluctuation of 1.87% [1]. - On August 21, the net inflow of main funds was 9.74 million yuan, while the net outflow over the past five days totaled 112 million yuan [1].